Acrivon Therapeutics

About:

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Website: http://www.acrivon.com/

Top Investors: Wellington Management, RA Capital Management, Sands Capital Ventures, Perceptive Advisors, Alexandria Venture Investments

Description:

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success. They specifically apply its approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single-gene driver mutations or synthetic lethal contexts. The company aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials.